These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 25072932)

  • 1. CDKN2A(p16) and HRAS are frequently mutated in vulvar squamous cell carcinoma.
    Trietsch MD; Spaans VM; ter Haar NT; Osse EM; Peters AA; Gaarenstroom KN; Fleuren GJ
    Gynecol Oncol; 2014 Oct; 135(1):149-55. PubMed ID: 25072932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular events in the pathogenesis of vulvar squamous cell carcinoma.
    Xing D; Fadare O
    Semin Diagn Pathol; 2021 Jan; 38(1):50-61. PubMed ID: 33032902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic mutation profiling of vulvar cancer: Exploring therapeutic targets.
    Zięba S; Kowalik A; Zalewski K; Rusetska N; Goryca K; Piaścik A; Misiek M; Bakuła-Zalewska E; Kopczyński J; Kowalski K; Radziszewski J; Bidziński M; Góźdź S; Kowalewska M
    Gynecol Oncol; 2018 Sep; 150(3):552-561. PubMed ID: 29980281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent genetic alterations and biomarker expression in primary and metastatic squamous cell carcinomas of the vulva.
    Xing D; Liu Y; Park HJ; Baek I; Tran H; Cheang G; Novo J; Dillon J; Matoso A; Farmer E; Cheng MA; Tsai YC; Lombardo K; Conner MG; Vang R; Hung CF; Wu TC; Song W
    Hum Pathol; 2019 Oct; 92():67-80. PubMed ID: 31437519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic profiles of Japanese patients with vulvar squamous cell carcinoma.
    Fujii E; Kato MK; Yamaguchi M; Higuchi D; Koyama T; Komatsu M; Hamamoto R; Ishikawa M; Kato T; Kohno T; Shiraishi K; Yoshida H
    Sci Rep; 2024 Jun; 14(1):13058. PubMed ID: 38844774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of invasive and in situ squamous neoplasia of the vulva and implications for morphologic diagnosis and outcome.
    Tessier-Cloutier B; Pors J; Thompson E; Ho J; Prentice L; McConechy M; Aguirre-Hernandez R; Miller R; Leung S; Proctor L; McAlpine JN; Huntsman DG; Gilks CB; Hoang LN
    Mod Pathol; 2021 Feb; 34(2):508-518. PubMed ID: 32792599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No evidence of oncogenic KRAS mutations in squamous cell carcinomas of the anogenital tract and head and neck region independent of human papillomavirus and p16(INK4a) status.
    Prigge ES; Urban K; Stiegler S; Müller M; Kloor M; Mai S; Ottstadt M; Lohr F; Wenz F; Wagner S; Wittekindt C; Klussmann JP; Hampl M; von Knebel Doeberitz M; Reuschenbach M
    Hum Pathol; 2014 Nov; 45(11):2347-54. PubMed ID: 25257576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Landscape of Vulvar Squamous Cell Carcinoma.
    Carreras-Dieguez N; Guerrero J; Rodrigo-Calvo MT; Ribera-Cortada I; Trias I; Jares P; López Del Campo R; Saco A; Munmany M; Marimon L; Ferrando M; Vega N; Del Pino M; Torné A; Ordi J; Rakislova N
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vulvar Squamous Cell Carcinoma (VSCC) as Two Diseases: HPV Status Identifies Distinct Mutational Profiles Including Oncogenic Fibroblast Growth Factor Receptor 3.
    Weberpals JI; Lo B; Duciaume MM; Spaans JN; Clancy AA; Dimitroulakos J; Goss GD; Sekhon HS
    Clin Cancer Res; 2017 Aug; 23(15):4501-4510. PubMed ID: 28377483
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of molecular targets in vulvar cancers.
    Palisoul ML; Mullen MM; Feldman R; Thaker PH
    Gynecol Oncol; 2017 Aug; 146(2):305-313. PubMed ID: 28536037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.
    Gleber-Netto FO; Zhao M; Trivedi S; Wang J; Jasser S; McDowell C; Kadara H; Zhang J; Wang J; William WN; Lee JJ; Nguyen ML; Pai SI; Walline HM; Shin DM; Ferris RL; Carey TE; Myers JN; Pickering CR;
    Cancer; 2018 Jan; 124(1):84-94. PubMed ID: 29053175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes.
    Kortekaas KE; Bastiaannet E; van Doorn HC; de Vos van Steenwijk PJ; Ewing-Graham PC; Creutzberg CL; Akdeniz K; Nooij LS; van der Burg SH; Bosse T; van Poelgeest MIE
    Gynecol Oncol; 2020 Dec; 159(3):649-656. PubMed ID: 32972785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and epigenetic changes in vulvar squamous cell carcinoma and its precursor lesions: a review of the current literature.
    Trietsch MD; Nooij LS; Gaarenstroom KN; van Poelgeest MI
    Gynecol Oncol; 2015 Jan; 136(1):143-57. PubMed ID: 25448458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of full coding sequence of the TP53 gene in invasive vulvar cancers: Implications for therapy.
    Kashofer K; Regauer S
    Gynecol Oncol; 2017 Aug; 146(2):314-318. PubMed ID: 28527674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic Mutation Profiling in Premalignant Lesions of Vulvar Squamous Cell Carcinoma.
    Zięba S; Pouwer AW; Kowalik A; Zalewski K; Rusetska N; Bakuła-Zalewska E; Kopczyński J; Pijnenborg JMA; de Hullu JA; Kowalewska M
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational signatures and chromosome alteration profiles of squamous cell carcinomas of the vulva.
    Han MR; Shin S; Park HC; Kim MS; Lee SH; Jung SH; Song SY; Lee SH; Chung YJ
    Exp Mol Med; 2018 Feb; 50(2):e442. PubMed ID: 29422544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation.
    Tinhofer I; Budach V; Saki M; Konschak R; Niehr F; Jöhrens K; Weichert W; Linge A; Lohaus F; Krause M; Neumann K; Endris V; Sak A; Stuschke M; Balermpas P; Rödel C; Avlar M; Grosu AL; Abdollahi A; Debus J; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; Baumann M;
    Eur J Cancer; 2016 Apr; 57():78-86. PubMed ID: 26896955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PIK3CA, HRAS and KRAS gene mutations in human penile cancer.
    Andersson P; Kolaric A; Windahl T; Kirrander P; Söderkvist P; Karlsson MG
    J Urol; 2008 May; 179(5):2030-4. PubMed ID: 18355852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TP53 and CDKN2a mutations in never-smoker oral tongue squamous cell carcinoma.
    Heaton CM; Durr ML; Tetsu O; van Zante A; Wang SJ
    Laryngoscope; 2014 Jul; 124(7):E267-73. PubMed ID: 24431303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.
    van Ginkel JH; de Leng WW; de Bree R; van Es RJ; Willems SM
    Oncotarget; 2016 Sep; 7(38):61575-61586. PubMed ID: 27528217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.